Medicinal Chemistry In The Path Of Drug Discovery

Abstract

The foundation for a potential new therapeutic begins with hit identification, where novel compounds exhibit desired biological activity. Hits can arise from rational drug design and natural product discovery, with intuition and expertise playing a crucial role in successful identification. High-throughput screening (HTS) rapidly screens large compound libraries for potential hits, while computational methods predict biological activity, accelerating drug discovery and development. Fragment-based drug design builds larger molecules from smaller fragments. Once hits are identified, the next steps involve selecting and prioritizing the most promising compounds for further development. Optimization focuses on enhancing binding affinity and efficacy, minimizing off-target effects and toxicity, and improving absorption, distribution, metabolism, elimination, and toxicity (ADMET) properties. Researchers identify the pharmacophore, critical organizational geographies responsible for biological activity, and consider properties like solubility, permeability, and metabolic stability that influence drug efficacy and safety. Specific optimization strategies include Structure-Activity Relationships (SAR), understanding how structural modifications affect biological activity, and common chemical transformations used in drug optimization. Predictive modeling aids in designing new compounds and predicting properties. Clear criteria guide the selection of compounds to advance into preclinical development.